Brontictuzumab

From WikiMD.org
Jump to navigation Jump to search

Brontictuzumab

Brontictuzumab (pronounced bron-tic-tu-zu-mab) is a monoclonal antibody designed for the treatment of cancer.

Etymology

The name "Brontictuzumab" is derived from the Greek words "bronte" meaning thunder, "ictus" meaning stroke, and "mab" is an abbreviation for monoclonal antibody.

Definition

Brontictuzumab is a type of monoclonal antibody that is being studied in the treatment of certain types of cancer. It binds to a protein called Notch1, which is found on the surface of some types of cancer cells, and may kill them or stop them from growing.

Related Terms

  • Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Notch1: A protein that in humans is encoded by the NOTCH1 gene. It is involved in the development of many types of cells, and it may also play a role in cancer.
  • Cancer: A term for diseases in which abnormal cells divide without control and can invade nearby tissues.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski